This trial is testing whether adding chemotherapy before and after surgery is better than just after surgery for treating gallbladder cancer.
- Stage IIB Gallbladder Cancer
- Stage III Gallbladder Cancer
- Stage IIIB Gallbladder Cancer
- Stage IIIA Gallbladder Cancer
- Stage II Gallbladder Cancer
- Stage IIA Gallbladder Cancer
1 Primary · 4 Secondary · Reporting Duration: Up to 5 years
Awards & Highlights
2 Treatment Groups
Arm I (surgery, adjuvant therapy)
1 of 2
Arm II (neoadjuvant therapy, surgery, adjuvant therapy)
1 of 2
186 Total Participants · 2 Treatment Groups
Primary Treatment: Lymphadenectomy · No Placebo Group · Phase 2 & 3
Who is running the clinical trial?
Age 18+ · All Participants · 1 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
What is the standard procedure for Lymphadenectomy?
"Lymphadenectomy, which is the surgical removal of lymph nodes, is most often used to treat neoplasm metastasis. However, it is also a viable option for treating small cell lung cancer (sclc), urinary bladder, and advanced testicular cancer." - Anonymous Online Contributor
Are there other scientific papers which explore Lymphadenectomy in detail?
"Out of the 1064 active clinical trials studying Lymphadenectomy, 361 are in Phase 3. The majority of these Lymphadenectomy trials are based in Shanghai; however, there are 53176 total locations running trials for Lymphadenectomy." - Anonymous Online Contributor